# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Biden announces plan to reclassify marijuana from Schedule I to III, reversing inequities and removing barriers for Americans. ...
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits ...
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decisi...
On Tuesday, cannabis stocks fell in early trading before rebounding and trending higher in the afternoon. Some of the upward mo...
'Florida has a million medical card holders, 23 million people living in the state, 130 million visitors a year — it's ...
Explore key cannabis industry trends, ETF shifts, and regulatory anticipations with expert Jesse Redmond. Insights on AYR Welln...
Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Hu...
The landscape of cannabis stocks is undergoing a significant shift, with recent weeks marking a robust uptick in market perform...
Ohio's cannabis legalization sparks market euphoria and fuels hopes of federal reform. Explore the investor impact and Sena...